A patient has died in a clinical trial for a gene therapy, with the cause of death still unknown. The trial was for a brain-targeting gene therapy, and the death has raised concerns about the safety of this type of treatment. The gene therapy in question is also being explored for use in treating Parkinson's disease, among other conditions.